01 April 2004
Synergistic efficacy of magnesium sulfate and FK506 on cerebral ischemia-induced infarct volume in gerbil
Shu-Ying Chung, Jing-Ying Lin, Ming-Cheng Lin, Hui-Ming Liu, Ming-Fu Wang, Fu-Chou ChengMed Sci Monit 2004; 10(4): BR105-108 :: ID: 11617
Abstract
Background: In this study, we administered intraperitoneal magnesium sulfate (90 mg/kg), either alone or in combination with FK506 (0.5 mg/kg) in order to investigate the neuroprotective synergetic effects of both, 30 min before permanent occlusion of the middle cerebral artery (MCA) in gerbil.
Material/Methods: Postmortem infarct volume was determined by quantitative image analysis of triphenyltetrazolium-stained brain sections, collected at 1h, 3h and 24h after initiation of cerebral ischemia, to measure consistent infarct volumes of the post -ischemic gerbil brain. Twenty-four male gerbils were intraperitoneally injected with MgSO[sub]4[/sub] (n=7), FK506 (n=8), or MgSO[sub]4[/sub] +FK506 (n=9), 30 min before permanent MCA occlusion. The brains of the treated groups were stained at 24h after initiation of cerebral ischemia.
Results: Significant and consistent infarct volumes (78.3I3.6 mm3) were observed in the 24 H control group. The infarct volume in the MgSO[sub]4[/sub] + FK506 group was significantly reduced at each slice, compared to the untreated 24H control group (P<0.05). Magnesium sulfate reduced total infarct volume by 25.4% (P<0.05), FK506 by 41% (P<0.05), and MgSO4 +FK506 by 50.5% (P<0.05). Also, the infarct volume (38.7I5.2 mm3) in the MgSO4 + FK506 group was the smallest in all the treated groups, near the volumes seen in the untreated 3H group.
Conclusions: Acute administration of a combination of Mg SO4 and FK506 has a synergetic efficacy against brain damage by permanent focal cerebral ischemia.
Keywords: Cerebellum - drug effects, Cerebellum - pathology, Cerebral Infarction - drug therapy, Cerebral Infarction - pathology, Drug Synergism, Gerbillinae, Immunosuppressive Agents - pharmacology, Magnesium Sulfate - pharmacology, Tacrolimus - pharmacology, Cerebellum - pathology, Cerebral Infarction - pathology, Drug Synergism, Gerbillinae, Immunosuppressive Agents - pharmacology, Magnesium Sulfate - pharmacology, Tacrolimus - pharmacology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952